Please login to the form below

Not currently logged in
Email:
Password:

John Czekanski leaves Fishawack, dna adds to team and Porterhouse announces promotions

The latest med comms movers

John Czekanski leaves Fishawack

John Czekanski

As part of its structure development, Fishawack’s global commercial head, John Czekanski has decided to leave the group.

The group said Czekanski’s decision to depart was both “mutual” and “amicable” and he will leave the business on 12 September.

During his time at Fishawack, Czekanski played a role in the integration of JK Associates, where he was chief executive before moving to Fishawack.


dna Communications appoints Jade Seidman

Jade Seidman

Medical education group dna Communicatins has added to its team in the form of Jade Seidman, who joins as its new medical writer.

Seidman was most recently an associate project manager at Synergy Medical and prior to that she was a production editor at Springer Nature.


Porterhouse Medical announces promotions and new team member

Medical communications firm Porterhouse Medical has announced two team member promotions.

Rebecca Thomas

Rebecca Thomas (pictured above) is promoted to an account manager following her work in delivering a series of events and projects.

Meanwhile, Beth Wynne-Evans has been promoted to a medical writer after her first year based in the group’s scientific services team.

Taking up a new role at Porterhouse Medical however, is Devdutt Sharma (pictured below), who joins as the group’s new associate medical writer.

Devdutt Sharma

Sharma has more than five years of scientific experience in an academic environment and has a PhD in molecular cell biology.

Article by
Gemma Jones

22nd August 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics